DRUG TRIAL FOR 'CURE' TO LUPUS
Daily Mirror UK|November 08, 2024
Therapy could revolutionise patients' lives
MARTIN BAGOT
DRUG TRIAL FOR 'CURE' TO LUPUS

THE first British patients are trialling a "groundbreaking" drug to cure autoimmune conditions such as lupus and multiple sclerosis.

Until now, CAR T-cell therapy has only been available in the UK for cancer patients but three people are now receiving it for lupus.

Medics hope the one-time treatment, which genetically modifies the immune system to attack problem cells, could prevent life-threatening damage to the heart, lungs, brain or kidneys.

In lupus, B cells become overactive and produce autoantibodies that attack healthy cells. It causes swollen joints, fevers, hair loss, stomach pain and can lead to kidney failure. CAR-T therapy works by genetically modifying T cells to target and eliminate these B cells.

Denne historien er fra November 08, 2024-utgaven av Daily Mirror UK.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra November 08, 2024-utgaven av Daily Mirror UK.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.